Overview

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke The primary hypothesis of this study is; This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo
Phase:
Phase 4
Details
Lead Sponsor:
Asan Medical Center
Collaborator:
Dong-A ST Co., Ltd.
Treatments:
Citalopram
Dexetimide